🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CAN...
Status
Active Not Recruiting
Location
Arkansas Children's Hospital
Start Date
2022-11-10
Trial ID
NCT05291091
Treatments Being Tested
EDG-5506-203 MESA is an open-label extension study to assess the long-term ...
Status
Enrolling By Invitation
Location
Arkansas Children's Hospital
Start Date
2023-11-02
Trial ID
NCT06066580
Treatments Being Tested
The ARCH study was an open-label, single-center, Phase 1b study of sevasemt...
Status
Completed
Location
Rare Disease Research
Start Date
2021-12-28
Trial ID
NCT05160415
Treatments Being Tested
The LYNX study is a 2-part, multicenter, Phase 2 study of safety, pharmacok...
Status
Active Not Recruiting
Location
Arkansas Children's Hospital
Start Date
2022-10-24
Trial ID
NCT05540860
Treatments Being Tested
The FOX study is a 2-part, multicenter, Phase 2 study of safety, pharmacoki...
Status
Active Not Recruiting
Location
UCLA Medical Center
Start Date
2024-03-22
Trial ID
NCT06100887
Treatments Being Tested
The purposes of this Phase 1 study of sevasemten are to: 1. Evaluate the e...
Status
Completed
Location
Celerion
Start Date
2025-01-08
Trial ID
NCT06916897
Treatments Being Tested